By staff writers

August 9, 2018 -- Radiopharmaceutical developer Navidea Biopharmaceuticals has posted lower revenue for its second quarter (end-June 30).

Total revenue for the quarter was $542,000, compared with $612,000 in the second quarter of last year. Revenue for the first six months of 2018 was $819,000, compared with $1.2 million for the same period in 2017.

However, the company's net loss for the quarter decreased to $2.4 million, dropping from $5.2 million in the same quarter of 2017. Its net loss for the six-month period was $9.1 million, compared with net income of $80.4 million in 2017.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking